IDCases
(Jan 2025)
A new approach to treat carbapenem resistant Acinetobacter baumannii (CRAB) bacteremia using sulbactam-avibactam combination: A case report
Sameer Alzaidi,
Manahil Alharthi,
Hams Alshammamri,
Yasir Almalki,
Osama Almalki,
Shahad Alqahtani,
Mohammed Alosaimi,
Nouran Althumali
Affiliations
Sameer Alzaidi
Corresponding author.; Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Manahil Alharthi
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Hams Alshammamri
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Yasir Almalki
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Osama Almalki
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Shahad Alqahtani
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Mohammed Alosaimi
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Nouran Althumali
Department of Infectious Diseases, King Abdul-Aziz Specialist Hospital, Taif Health Cluster, Taif, Saudi Arabia
Journal volume & issue
Vol. 41
Abstract
Read online
Carbapenem resistant Acinetobacter baumannii (CRAB) infections are serious disease that can be fatal. Only a few therapeutic options are available, with conflicting data for their meaningful clinical outcomes. Here, we report a case of 83-year-old female CRAB bacteremia that was successfully treated with ceftazidime-avibactam and ampicillin-sulbactam combination after failing guidelines directed therapy.
Keywords
WeChat QR code
Close
